Ephedra ban lawsuit
This article was originally published in The Tan Sheet
Executive Summary
FDA is facing a second lawsuit over the ephedra ban by the marketer of Thermalean weight-loss supplement, according to a complaint filed in Birmingham, Ala. federal court March 23. The National Institute for Clinical Weight Loss alleges the agency did not meet its burden of proof in finding ephedra supplements presented unreasonable risk and violated the Administrative Procedures Act. NICW was barred from making drug claims for Thermalean under a 2003 consent decree (1"The Tan Sheet" Oct. 13, 2003, p. 4)...